Two more biotechnology products receive orphan drug designation

被引：0

|

作者：

不详

机构：

来源：

BIOTECHNOLOGY LAW REPORT | 2000年 / 19卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

收藏

页码：417 / 417

页数：1

相关论文

共 50 条

[31] MP-470 granted orphan drug designation
不详
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (09) : 1373 - 1373
[32] Do investors value the FDA orphan drug designation?
Miller, Kathleen L.
[J]. ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
[33] OBTAINING ORPHAN DRUG PRODUCTS
SMITH, MA
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1987, 44 (08): : 1752 - 1753
[34] European orphan drug designation for dehydrodidemnin B for multiple myeloma
不详
[J]. DRUG NEWS & PERSPECTIVES, 2004, 17 (09) : 578 - 578
[35] Reports Isavuconazole Granted Orphan Drug Designation by US FDA
不详
[J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 (04) : II - II
[36] The routes to orphan drug designation - our recent experience at the FDA
Lev, Daniel
Thorat, Chandana
Phillips, Ian
Thomas, Mathew
Imoisili, Menfo A.
[J]. DRUG DISCOVERY TODAY, 2012, 17 (3-4) : 97 - 99
[37] Hemophilia drug OBI-1 receives orphan drug designation in Europe
Reeve, Emily
[J]. EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (06) : 662 - 662
[38] Drugs and biologics receiving FDA orphan drug designation: an analysis of the most frequently designated products and their repositioning strategies
Miller, Kathleen L.
Kraft, Selma
Ipe, Abraham
Fermaglich, Lewis
[J]. EXPERT OPINION ON ORPHAN DRUGS, 2021, 9 (11-12): : 265 - 272
[39] Experimental use and the orphan drug act: A biotechnology conundrum
Koivuniemi, PJ
[J]. NATURE BIOTECHNOLOGY, 1996, 14 (04) : 511 - 512
[40] THE ORPHAN DRUG PRODUCTS - ANOTHER SOLUTION
ARCHAMBAULT, GF
[J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (01): : 80 - 80

← 1 2 3 4 5 →